Blackstone Announces Agreement to Acquire Clarus, a Leading Life Sciences Investment Firm

Firm Announces Launch of Blackstone Life Sciences Investment Platform New York – Blackstone (NYSE:BX) today announced that it has agreed to acquire Clarus, a leading global life sciences investment firm that has raised $2.6 billion since its founding.  Clarus, with offices in the life sciences hubs of Boston and San Francisco, is focused on funding growth-stage [...]

IQVIA and Genomics England Launch the First Real-World Research Platform with Integrated Clinical and Genomic Data

DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- IQVIA™ (NYSE:IQV) and Genomics England today announced a collaboration to develop a platform that will connect clinical and de-identified genomics data to accelerate treatment advancements for patients. This alliance will enable faster and more efficient drug research, more robust evidence to support treatment value, and greater access [...]

INFICON Acquires Final Phase Systems

End-to-end Software Solution for Fully Connected Smart Fab of the Future SYRACUSE, N.Y.--On October 1, 2018 INFICON Inc. (SWX:IFCN), a leading supplier of vacuum instrumentation and process control software to the semiconductor manufacturing industry acquired all assets of Final Phase Systems (FPS) of Austin, Texas, USA. Founded in 2009 by Industrial Engineers from AMD/Spansion’s Fab25, FPS has grown to [...]

Celyad Announces Exclusive Agreement for Horizon Discovery’s shRNA Platform to Develop Next-Generation Allogeneic CAR-T Therapies

Location: Cambridge, UK In vivo study results to be presented at the 2018 SITC Annual Meeting Celyad (Paris:CYAD) (Brussels:CYAD) (NASDAQ:CYAD) (Euronext Brussels and Paris, and NASDAQ: CYAD), a clinical-stage biopharmaceutical company focused on the development of specialized CAR-T cell-based therapies, today announced an exclusive agreement with Horizon Discovery Group plc (LSE: HZD), for the use [...]

AXCELEAD DRUG DISCOVERY PARTNERS AND ERS GENOMICS ENTER INTO CRISPR/CAS9 LICENSE AGREEMENT

Fujisawa, Japan and Dublin, Ireland – Axcelead Drug Discovery Partners, Inc.(hereinafter referred to as “Axcelead”) and ERS Genomics Limited (hereinafter referred to as “ERS Genomics”) announced today a non-exclusive license agreement to provide Axcelead with worldwide access to ERS Genomics’ CRISPR/Cas9 genome editing intellectual property to enhance their drug discovery service offering. ERS Genomics holds rights [...]

NanoString Announces the University of Oxford Selected as the Winning Recipient in GeoMx Digital Spatial Profiler Grant Program

DSP to be Applied to Transplant Research of Regulatory T Cell Therapy in Kidney Transplantation SEATTLE -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the University of Oxford has been selected as the winning recipient of a grant for a GeoMx™ Digital Spatial Profiler (DSP) [...]

Merck Opens M Lab™ Collaboration Center in São Paulo, Brazil

Merck today officially opened a state-of-the-art M Lab™ Collaboration Center in Brazil, serving the Latin America region.  SÃO PAULO, BRAZIL New collaboration center to provide support from pre-clinical through full-scale production in a non-GMP environment Hands-on customer access to Merck’s product portfolio, technical expertise São Paulo, Brazil, October 4, 2018 – Merck, the vibrant science and technology company, [...]

Fluidigm Announces Agreement with DNA Software to Offer Secondary CNV Analysis for Biomark HD

Combining high-performance automated microfluidics with easy-to-use software to streamline CNV detection for translational and clinical research SOUTH SAN FRANCISCO, Calif. -- Fluidigm Corporation (NASDAQ:FLDM) today announced that it has entered into a non-exclusive distribution agreement with DNA Software, Inc. to provide CopyCount-CNV™ software for use with the Fluidigm Biomark™ HD system. Copy number variation (CNV) plays an important role [...]

IonSense and Cayman Chemical Collaboration Reaches 1000 Compound Milestone in Development of MS Library of Drugs of Abuse

New database enables the rapid screening and identification of drugs by Direct Analysis in Real Time (DART®) mass spectrometry. SAUGUS, Mass. -- IonSense, Inc. has announced that in collaboration with Cayman Chemical, Inc. they have built and validated a mass spectral database of 1000 compounds for the rapid screening of drugs of abuse using Direct [...]

NEW AutoScratch™ Wound Making Tool

Do you want better reproducibility and lower variability in your scratch wound assays? AutoScratch automatically creates reproducible scratch wounds in confluent cell monolayers grown in 96- and 24-well microplates, eliminating the variables inherent in manual scratch methods. Operation is simple with pushbutton activation, easily replaceable scratch tips and automated pre-programed cleaning and decontamination routines to [...]

Access IBO on Knowledge Center